Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
584
1 119.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one VIJAYA stock under the Base Case scenario is 660.09 INR. Compared to the current market price of 1 048.8 INR, Vijaya Diagnostic Centre Ltd is Overvalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Vijaya Diagnostic Centre Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for VIJAYA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Vijaya Diagnostic Centre Ltd
Balance Sheet Decomposition
Vijaya Diagnostic Centre Ltd
Current Assets | 2.1B |
Cash & Short-Term Investments | 1.9B |
Receivables | 162.4m |
Other Current Assets | 97.6m |
Non-Current Assets | 7.7B |
Long-Term Investments | 113.4m |
PP&E | 6.1B |
Intangibles | 1.4B |
Other Non-Current Assets | 93.2m |
Current Liabilities | 728.7m |
Accounts Payable | 329.5m |
Other Current Liabilities | 399.2m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 2.4B |
Other Non-Current Liabilities | 136.4m |
Earnings Waterfall
Vijaya Diagnostic Centre Ltd
Revenue
|
5.8B
INR
|
Cost of Revenue
|
-699.1m
INR
|
Gross Profit
|
5.1B
INR
|
Operating Expenses
|
-3.4B
INR
|
Operating Income
|
1.7B
INR
|
Other Expenses
|
-468.4m
INR
|
Net Income
|
1.2B
INR
|
Free Cash Flow Analysis
Vijaya Diagnostic Centre Ltd
INR | |
Free Cash Flow | INR |
VIJAYA Profitability Score
Profitability Due Diligence
Vijaya Diagnostic Centre Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Vijaya Diagnostic Centre Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
VIJAYA Solvency Score
Solvency Due Diligence
Vijaya Diagnostic Centre Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Vijaya Diagnostic Centre Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VIJAYA Price Targets Summary
Vijaya Diagnostic Centre Ltd
According to Wall Street analysts, the average 1-year price target for VIJAYA is 926.74 INR with a low forecast of 666.6 INR and a high forecast of 1 202.25 INR.
Dividends
Current shareholder yield for VIJAYA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Vijaya Diagnostic Centre Ltd. engages in the provision of diagnostic services. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-09-14. The firm is engaged in the business of providing a range of diagnostic services spanning pathological investigations, basic and high-end radiology, nuclear medicine and related healthcare services. The firm operates through the Diagnostic Services segment. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetics and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans, single photon emission computed tomography (SPECT) and advanced positron emission tomography CT (PET CT). The firm also offers a range of health and wellness packages to its customers as per their requirements. The firm has a diagnostic network with over 90 centers spread across 15 cities.
Contact
IPO
Employees
Officers
The intrinsic value of one VIJAYA stock under the Base Case scenario is 660.09 INR.
Compared to the current market price of 1 048.8 INR, Vijaya Diagnostic Centre Ltd is Overvalued by 37%.